High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma

Cancer

Volumn 88, Issue 10, 2000, Pages 2239-2245

  Seo, Yousuke ^a   Baba, Hideo ^a   Fukuda, Toshiro ^a   Takashima, Masaki ^b   Sugimachi, Keizo ^b  

^a NATIONAL KYUSHU CANCER CENTER   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Immunohistochemistry; Microvessel density; Survival; Vascular endothelial growth factor

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER SURVIVAL; HUMAN; HUMAN TISSUE; LIVER METASTASIS; PANCREAS ADENOCARCINOMA; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, DUCTAL, BREAST; ENDOTHELIAL GROWTH FACTORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LYMPHOKINES; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PROGNOSIS; REGRESSION ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034657029     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000515)88:10<2239::AID-CNCR6>3.0.CO;2-V     Document Type: Article

References (37)

1. Yeo CJ, Abrams RA, Grochow LB, Sohn TA, Ord SE, Huban RH, et al. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. Ann Surg 1997;225:621-36.
2. Kayahara M, Nagakawa T, Ueno K, Ohta T, Takeda T, Miyazaki I. An evaluation of radical resection for pancreatic cancer based on the mode of recurrence as determined by autopsy and diagnostic imaging. Cancer 1993; 72:2118-23.
3. Leung DW, Cathians G, Kuang WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246:1305-9.
4. Weidener N, Folkman J, Pozza F, Bevilacqua P, Aired EN, Moore DH, et al. Tumor angiogenesis: a new significant and independent prognostic indicator in early stage breast carcinoma. J Natl Cancer Inst 1993;84:1875-87.
5. Volm M, Koomagi R, Mattern J. Prognostic value of vascular endothelial growth factor and its receptor flt-1 in squamous cell lung cancer. Int J Cancer 1997;74:64-8.
6. Inoue K, Ozeki Y, Suganuma T, Sugiura Y, Tanaka S. Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Cancer 1997;79:206-13.
7. Maeda K, Chung Y, Takatsuka S, Ogawa Y, Sawada T, Yamashita Y, et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol 1995;13:477-81.
8. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
9. Fontanini G, Bigimi D, Vignati S, Basalo F, Mussi A, Lucchi M, et al. Microvessel count predicts metastatic disease and survival in non small cell lung cancer. J Pathol 1995;177:57-63.
10. Gasparini G, Weidner N, Maluta S. Intratumoral microvessel density p53 protein: correlation with metastasis in head and neck squamous cell carcinoma. Int J Cancer 1993;55:739-44.
11. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ. Tumor angiogenesis in advanced staged ovarian carcinoma. Am J Pathol 1995;147:33-41.
12. Köppel G, Solcia E, Longnecker DS, Capell C, Sobin LH. Histological typing of tumors of the exocrine pancreas (World Health organization). 2nd edition. Berlin: Springer-Verlag, Inc., 1996:15-21.
13. Kuroda M, Oka T, Oka Y, Yamochi T, Ohtubo K, Mori S, et al. Colocalization of vascular endothelial growth factor (vascular permiability factor) and insulin in pancreatic islet cells. J Clin Endocrinol Metab 1995;80:3196-200.
14. Christophori G, Naik P, Hanahan D. Vascular endothelial growth factor and its receptors, flt-1 and flk-1, are expressed in normal pancreatic islets and throughout islet tumorigenesis. Mol Endocrinol 1995;9:1760-70.
15. Dixon WJ, editor. BMDP statistical software. Berkeley, CA: University of California Press, 1988:229-718.
16. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
17. Imanishi K, Yamaguchi K, Suzuki M, Honda S, Yanaihara N, Abe K. Production of transforming growth factor in human tumour cell lines. Br J Cancer 1989;59:761-5.
18. Yoneda J, Kuniyasu H, Crispens MA, Price JE, Bucana CD, Fidler IJ. Expression of angiogenesis-related genes and progression of human ovarian carcinomas in nude mice. J Natl Cancer Inst 1998;90:447-54.
19. Van Roozendaal KE, Klijn JG, Van Ooijen B, Claassen C, Eggermont AM, Henzen-Logmans SC, et al. Differential regulation of breast tumor cell proliferation by stromal fibroblasts of various breast tissue sources. Int J Cancer 1996;65: 120-5.
20. Zumkeller W, Schonfleld PN. Growth factors, cytokines and soluble forms of receptor molecules in cancer patients. Anticancer Res 1995;15:343-8.
21. Weidner N, Caroll PR, Flax J, Blumenfeld W, Folkman J. Tumor angiogenesis correlates with metastasis in invasive prostate cancer. Am J Pathol 1993;143:401-9.
22. Abdulrauf SI, Edvardsen K, Ho KL, Yang XY, Rock JF, Rosenblum ML. Vascular endothelial growth factor expression and vascular density as prognostic markers of survival in patients with low-grade astrocytoma. J Neurosurg 1998;88:513-20.
23. Egawa S, Tsutumi M, Konishi Y, Kobari M, Matsuno S, Nagasaki K, et al. The role of angiogenesis in the tumor growth of Syrian hamster pancreatic cancer cell line HPD-NR. Gastroenterology 1995;108:1526-33.
24. Ellis LM, Takahashi Y, Fenoglio CJ, Clearly KR, Bucana CD, Evans DB. Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma. Eur J Cancer 1998;34:337-40.
25. Maeda K, Chung Y, Ogawa Y, Takatsuka S, Kang S, Ogawa M, et al. Prognostic value of vascular endothelial grwoth factor expression in gastric carcinoma. Cancer 1996;77: 858-63.
26. Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Br Cancer Res Treat 1995;36:193-204.
27. Takanami I, Tanaka F, Hashizume T, Kodaira S. Vascular endothelial growth factor and its receptor correlate with angiogenesis and survival in pulmonary adenocarcinoma. Anticancer Res 1997;17:2811-4.
28. Obermair A, Kohlberger P, Bancher-Todesca D, Tempter C, Sliutz G, Leodolter S, et al. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol Oncol 1996;63:204-9.
29. Toi M, Inada K, Suzuki H, Tominaga T. Tumor angiogenesis in breast cancer: its importance as a prognostic indicator and the association with vascular endothelial growth factor expression. Br J Cancer Res Treat 1995;36:193-204.
30. Mattern J, Koomagi R, Volm M. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma. Br J Cancer 1996;73:931-4.
31. Takahashi Y, Kitadai Y, Bucana CD, Clearly KR, Ellis LM. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55: 3964-8.
32. Liotta LA, Kleinerman J, Saidel GM. The significance of heterogenous tumor cell clumps in the metastatic process. Cancer Res 1976;36:889-94.
33. Nagy JA, Brown LF, Senger DR, Lanir N, Van De Water L, Dvorak AM, et al. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim Biophys Acta 1988;948:305-26.
34. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991;151(Suppl):5054-9.
35. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
36. Spitz FE, Abbruzzese JL, Lee JE, Pisters PWT, Lowry AM, Fenoglio CJ, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol 1997;15:928-37.
37. Ishikawa O, Ohigashi H, Imaoka S, Sasaki Y, Kameyama M, Nakamori S, et al. Regional chemotherapy to prevent hepatic metastasis after resection of pancreatic cancer. Hepatogastroenterology 1997;44:1541-6.